ArticleFrontiers in medicine2026

A multi-database pharmacovigilance study reveals distinctive immunosuppressive and opportunistic infection disproportionality signals with bevacizumab and temozolomide combination therapy in glioblastoma.

Yong Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.